Unlock instant, AI-driven research and patent intelligence for your innovation.

Compositions for effective management of fibroblast-like synoviocytes mediated rheumatoid arthritis

a technology of fibroblasts and synoviocytes, applied in the direction of drug compositions, anti-noxious agents, plant/algae/fungi/lichens ingredients, etc., can solve the problems of hypersensitivity, especially immune related, and achieve the effect of inhibiting proliferation and migration

Pending Publication Date: 2022-06-23
SAMI SABINSA GRP LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention is a method and composition for inhibiting the proliferation and migration of fibroblast-like synoviocytes (FLS) in a mammal, as well as regulating the balance between T-helper-17 (Th-17) and T-cell (Treg) in the spleen. The composition can be a combination of enriched BDMC curcuminoids and BPS. The method involves administering the composition to the mammal. The technical effects of the invention include reducing inflammation and pain associated with rheumatoid arthritis, and promoting healing and regeneration of damaged tissues.

Problems solved by technology

Int. Immunopharmacol. 73, 539-551, 2019) Further, current treatment of RA using synthetic Disease-modifying antirheumatic drugs (DMARDs) and biological DMARDs either individually or in combination offers therapeutic strategies but show significant side effects including hypersensitivity, especially immune related.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions for effective management of fibroblast-like synoviocytes mediated rheumatoid arthritis
  • Compositions for effective management of fibroblast-like synoviocytes mediated rheumatoid arthritis
  • Compositions for effective management of fibroblast-like synoviocytes mediated rheumatoid arthritis

Examples

Experimental program
Comparison scheme
Effect test

example 1

and Culture of Fibroblast-Like Synoviocytes (FLS)

[0050]Synovial tissues were obtained from collagen induced arthritis rats under sterile conditions, according to the method followed by (Jinjun Zhao, Qingqing Onyang, Ziyou Hu, Qin Huang, Jing Wu, Ran Wang and Min Yang. A protocol for the culture and isolation of murine synovial fibroblasts. Biomedical Reports 5: 171-175, 2016).

[0051]FLS were isolated from synovial tissues by enzymatic digestion. In short, the tissues were separated into 1-mm3 blocks with microsurgery scissors. After which the tissues were incubated with 0.1% collagenase type II enzyme in DMEM supplemented with 10% FBS for enzymatic digestion at 37° C. for 45 min in an orbital shaker incubator (200 rpm).

[0052]After the incubation time, the tubes were vortexed vigorously for 1-2 min to release the cells and filtered using a 100 μm mesh strainer. The filtrate was centrifuged for 5 min at 1200 rpm, the cells were resuspended in DMEM supplemented with 10% FBS and 100 μg / m...

example 2

liferation Assay

[0053]WST-1 assay was used to measure the effect of different samples on FLS proliferation. FLS were seeded in 96-well plates at a density of 5×103 cells / well and incubated overnight at 37° C. under 5% CO2. Then, the cells were treated with different concentrations of the sample (AC3, C3, Cur, BDMC, DMC, BPS) as shown in the FIGS. 3-6 for 72 hours. After the treatment period, 100 μl WST-1 reagent (5015944001, Sigma, USA) diluted 1:10 in serum-free DMEM culture media was added to each well, and incubated at 37° C. under 5% CO2 for 2 h. The absorbance was measured at 450 nm with a reference wavelength of 610 nm. AC3 showed better inhibition of FLS proliferation at 20 μg / mL and 40 μg / mL (FIGS. 3 and 4) in a dose dependent manner. A comparative study of curcuminoid analogues in the inhibition of FLS proliferation showed a trend of BDMC>curcumin>DMC (FIG. 5) at 20 μg / mL, whereas BPS showed only 10% inhibition and the combination was much effective than the Boswellin PS (B...

example 3

e Analysis

[0054]FLS cells (8-104 cells / well) were seeded in 24-well plates and incubated overnight at 37° C. under 5% CO2. After synchronization in serum-free medium for 24 h, cells were treated with or without the presence of samples in DMEM 10% FBS for 24 h. After the treatment period, the cells were collected, suspended in ice cold PBS. After centrifugation, the cells were fixed by adding 70% ice cold ethanol dropwise to the pellet while vortexing and stored at 4° C. for 30 min. The cells were stained with propidium iodide (PI) solution (50 μg / ml) for 30 min at 37° C. in the dark. DNA content was analyzed by flow cytometry (BD FACS Celesta flow cytometer). AC3, BDMC among curcuminoids showed maximum inhibition of FLS replication (FIGS. 7, 8, 12, and 14), and FLS was arrested at G0 / G1 phase. Boswellin PS (BPS) showed inhibition only at 80 μg / mL (FIG. 8, FIG. 16). The effect of combination (AC3+BPS) on cell-cycle inhibition was better than the individual samples used (AC3 and BPS),...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to View More

Abstract

The disclosed invention relates to a method and compositions for use in inhibiting proliferation, migration of Fibroblast-like Synoviocytes (FLS) in a subject. The invention also discloses a composition and method for regulating imbalance in T-helper 17 (Th17), T-cell. The composition disclosed comprises 20-50% BDMC, 10-25% w / w DMC and 30-50% w / w curcumin, further comprising boswellic acids and polysaccharides in the range of 35-50% w / w and 35-45% w / w.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This is a non-provisional application claiming priority from U.S. provisional application No. 63 / 126,920 filed on 17 Dec. 2020, the contents of which are incorporated herein by reference.FIELD OF INVENTION[0002]The invention in general relates to a method and compositions for use in inhibiting proliferation, migration of Fibroblast-like Synoviocytes (FLS) in a subject. The invention also discloses a composition and method for regulating imbalance in T-helper 17 (Th17), T-cell. Still more specifically, the invention discloses the composition comprising 20-50% BDMC, 10-25% w / w DMC and 30-50% w / w curcumin, further comprising boswellic acids and polysaccharides from Boswellia serrata. BACKGROUND OF INVENTION[0003]The clinical manifestation of Rheumatoid arthritis (RA), an autoimmune synovial disease caused by a complex interaction between genetic and environmental factors, caused by synovial inflammation and joint damage. Fibroblast-like syno...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/12A61K31/19A61K36/324A61K9/48A61K9/00A61P19/02A61K47/12A61K47/26
CPCA61K31/12A61K31/19A61K36/324A61K47/26A61K9/0056A61P19/02A61K47/12A61K9/4866A61K31/23A61P39/06A61K9/2054A61K9/2059A61K9/2027A61K36/9066A61K36/71A23L33/105A61K2300/00A61P29/00A61K45/06A61K9/2009A61K9/2013A61K47/42A61P3/06A61K9/0053
Inventor MAJEED, MUHAMMEDNAGABHUSHANAM, KALYANAMMUNDKUR, LAKSHMI
Owner SAMI SABINSA GRP LTD